FDA-Inspected Site

FairyGene, Inc.

1 FDA inspection is on record for FairyGene, Inc. in Bristol, United States.

483· Form 483 issued

Bristol, United States · Last updated July 12, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-01-15.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
12 Jan 2026 – 15 Jan 2026Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

15 Jan 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Christina K Theodorou, Ofuje D Daniyan

15 Jan 2026
21 CFR 211.166(a)

Lack of written stability program

Cited by Christina K Theodorou, Ofuje D Daniyan

15 Jan 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Christina K Theodorou, Ofuje D Daniyan

15 Jan 2026
21 CFR 211.42(b)

Adequate space lacking to prevent mix-ups and contamination

Cited by Christina K Theodorou, Ofuje D Daniyan

15 Jan 2026
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Christina K Theodorou, Ofuje D Daniyan

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind FairyGene, Inc.'s 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat